Kyle Piskel sold $1,235 of ADPT
Chief Financial Officer at Adaptive Biotechnologies Corp. 248 shares at an average of $4.98, traded Nov 18, 2024, filed Nov 19, 2024.
Score components
- +22RoleCFO
- 0Trade size$1k at market
- 0Share of holdings soldSold 0.2% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +33.9%, 3m +84.6%, 6m +108.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-24-019373, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 18, 2024 | SOpen-market sale Common Stock | -248 | $4.98 | $1,235 | 154,330 | Nov 19, 2024 |
Related signals
Other insiders at Adaptive Biotechnologies Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 24Weak | Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | $948k 35,643 shares | -9% | |
| 22Weak | Adaptive Biotechnologies Corp | Susan Bobulsky Chief Commercial Officer, MRD | $193k 6,444 shares | -2% | |
| 22Weak | Adaptive Biotechnologies Corp | Francis Lo Chief People Officer | $758k 26,792 shares | -11% | |
| 25Weak | Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | $1.0M 35,643 shares | -9% | |
| 23Weak | Adaptive Biotechnologies Corp | Francis Lo Chief People Officer | $3.2M 115,406 shares | -34% | |
| 8Weak | Adaptive Biotechnologies Corp | Susan Bobulsky Chief Commercial Officer, MRD | $32k 1,195 shares | -0% | |
| 22Weak | ADPTsell Adaptive Biotechnologies Corp | Kyle Piskel Chief Financial Officer | $17k 1,929 shares | -1% | |
| 22Weak | ADPTsell Adaptive Biotechnologies Corp | Kyle Piskel Chief Financial Officer | $17k 1,929 shares | -1% | |
| 0Weak | Adaptive Biotechnologies Corp | Harlan S Robins Chief Scientific Officer | $503k 68,412 shares | -5% | |
| 0Weak | Adaptive Biotechnologies Corp | Harlan S Robins Chief Scientific Officer | $15k 1,698 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.